Study of the Plasma and Urinary cfDNA of in Kidney Transplant Patients
Recruiting
Observational Study
Transplant Rejection
Transplant Kidney
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 250 (estimated)
- Sponsor
- Poulet Geoffroy · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
It has been shown that the amount of circulating donor-cell-free DNA increases in patients with transplant rejection. Quantification of single nucleotide polymorphisms (SNPs) present in circulating donor DNA currently allows for early identification of transplant rejection, but not for characterization, i.e., identification of the affected renal fraction of the graft.
Recently, in healthy subject…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients living with a kidney transplant
* Admitted for suspected transplant rejection requiring a renal biopsy (RBB) as an indication
Exclusion Criteria:
* Patients with cognitive and mental disorders rendering them unable to express their non-opposition to participation in…
Contacts